Perfluorocarbon liquids in the management of complicated vitreoretinal conditions

W. F. Mieler, F. Chou, E. L. Arrindell, D. P. Han, Jose S Pulido, G. W. Abrams

Research output: Contribution to journalArticle

Abstract

Purpose. To review the trends it the usage of perfluoro-n-octane (PFO) over a 3-year time frame (1991-1993), and to evaluate the surgical success rate, within specific diagnoses. Methods. One hundred seventy-two consecutive pars plana vitrectomy cases involving the use of PFO were retrospectively analyzed. Indications for usage of PFO included (1) facilitation of retinal membrane dissection, (2) redundant retina following retinal membrane dissection, (3) giant retinal tears (4) flattening of retinectomy/retinotomy, and (5) several other miscellaneous causes. Results. Over the 3-year time frame of the study, PFO was utilized in 172 of 818 vitrectomy cases (21.0%); 39 of 238 (16.4%) in 1991, 62 of 300 (20.7%) in 1992, and in 71 of 280 (25.4%) in 1993. On a percentage basis, the PFO was utilized most frequently in giant retinal tears (97%), followed by penetrating trauma (40%). proliferative vitreoretinopathy (28%), diabetic vitrectomy (11%), and miscellaneous cases (8%). Individual diagnosis specific success rates will be reviewed, though combining all diagnoses over the 3-year time span, and with follow-up of 6 months, the anatomic success rate was 83.9%. Ambulatory visual acuity (5/200 or better) was achieved in 73.2%. Conclusions. PFO proved to be an extremely useful adjunct in the management of a variety of complex vitreoretinal conditions. While the PFO facilitated intraoperative retinal reattachment, its influence on the overall surgical success rate could not be fully determined due to the non-randomized nature of the study.

Original languageEnglish (US)
JournalInvestigative Ophthalmology and Visual Science
Volume37
Issue number3
StatePublished - Feb 15 1996
Externally publishedYes

Fingerprint

Fluorocarbons
Vitrectomy
Retinal Perforations
Dissection
Proliferative Vitreoretinopathy
Temazepam
Membranes
perfluorooctane
Visual Acuity
Retina
Wounds and Injuries

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Perfluorocarbon liquids in the management of complicated vitreoretinal conditions. / Mieler, W. F.; Chou, F.; Arrindell, E. L.; Han, D. P.; Pulido, Jose S; Abrams, G. W.

In: Investigative Ophthalmology and Visual Science, Vol. 37, No. 3, 15.02.1996.

Research output: Contribution to journalArticle

Mieler, W. F. ; Chou, F. ; Arrindell, E. L. ; Han, D. P. ; Pulido, Jose S ; Abrams, G. W. / Perfluorocarbon liquids in the management of complicated vitreoretinal conditions. In: Investigative Ophthalmology and Visual Science. 1996 ; Vol. 37, No. 3.
@article{d8b96176f3ec44a1aedf86669602ebb5,
title = "Perfluorocarbon liquids in the management of complicated vitreoretinal conditions",
abstract = "Purpose. To review the trends it the usage of perfluoro-n-octane (PFO) over a 3-year time frame (1991-1993), and to evaluate the surgical success rate, within specific diagnoses. Methods. One hundred seventy-two consecutive pars plana vitrectomy cases involving the use of PFO were retrospectively analyzed. Indications for usage of PFO included (1) facilitation of retinal membrane dissection, (2) redundant retina following retinal membrane dissection, (3) giant retinal tears (4) flattening of retinectomy/retinotomy, and (5) several other miscellaneous causes. Results. Over the 3-year time frame of the study, PFO was utilized in 172 of 818 vitrectomy cases (21.0{\%}); 39 of 238 (16.4{\%}) in 1991, 62 of 300 (20.7{\%}) in 1992, and in 71 of 280 (25.4{\%}) in 1993. On a percentage basis, the PFO was utilized most frequently in giant retinal tears (97{\%}), followed by penetrating trauma (40{\%}). proliferative vitreoretinopathy (28{\%}), diabetic vitrectomy (11{\%}), and miscellaneous cases (8{\%}). Individual diagnosis specific success rates will be reviewed, though combining all diagnoses over the 3-year time span, and with follow-up of 6 months, the anatomic success rate was 83.9{\%}. Ambulatory visual acuity (5/200 or better) was achieved in 73.2{\%}. Conclusions. PFO proved to be an extremely useful adjunct in the management of a variety of complex vitreoretinal conditions. While the PFO facilitated intraoperative retinal reattachment, its influence on the overall surgical success rate could not be fully determined due to the non-randomized nature of the study.",
author = "Mieler, {W. F.} and F. Chou and Arrindell, {E. L.} and Han, {D. P.} and Pulido, {Jose S} and Abrams, {G. W.}",
year = "1996",
month = "2",
day = "15",
language = "English (US)",
volume = "37",
journal = "Investigative Ophthalmology and Visual Science",
issn = "0146-0404",
publisher = "Association for Research in Vision and Ophthalmology Inc.",
number = "3",

}

TY - JOUR

T1 - Perfluorocarbon liquids in the management of complicated vitreoretinal conditions

AU - Mieler, W. F.

AU - Chou, F.

AU - Arrindell, E. L.

AU - Han, D. P.

AU - Pulido, Jose S

AU - Abrams, G. W.

PY - 1996/2/15

Y1 - 1996/2/15

N2 - Purpose. To review the trends it the usage of perfluoro-n-octane (PFO) over a 3-year time frame (1991-1993), and to evaluate the surgical success rate, within specific diagnoses. Methods. One hundred seventy-two consecutive pars plana vitrectomy cases involving the use of PFO were retrospectively analyzed. Indications for usage of PFO included (1) facilitation of retinal membrane dissection, (2) redundant retina following retinal membrane dissection, (3) giant retinal tears (4) flattening of retinectomy/retinotomy, and (5) several other miscellaneous causes. Results. Over the 3-year time frame of the study, PFO was utilized in 172 of 818 vitrectomy cases (21.0%); 39 of 238 (16.4%) in 1991, 62 of 300 (20.7%) in 1992, and in 71 of 280 (25.4%) in 1993. On a percentage basis, the PFO was utilized most frequently in giant retinal tears (97%), followed by penetrating trauma (40%). proliferative vitreoretinopathy (28%), diabetic vitrectomy (11%), and miscellaneous cases (8%). Individual diagnosis specific success rates will be reviewed, though combining all diagnoses over the 3-year time span, and with follow-up of 6 months, the anatomic success rate was 83.9%. Ambulatory visual acuity (5/200 or better) was achieved in 73.2%. Conclusions. PFO proved to be an extremely useful adjunct in the management of a variety of complex vitreoretinal conditions. While the PFO facilitated intraoperative retinal reattachment, its influence on the overall surgical success rate could not be fully determined due to the non-randomized nature of the study.

AB - Purpose. To review the trends it the usage of perfluoro-n-octane (PFO) over a 3-year time frame (1991-1993), and to evaluate the surgical success rate, within specific diagnoses. Methods. One hundred seventy-two consecutive pars plana vitrectomy cases involving the use of PFO were retrospectively analyzed. Indications for usage of PFO included (1) facilitation of retinal membrane dissection, (2) redundant retina following retinal membrane dissection, (3) giant retinal tears (4) flattening of retinectomy/retinotomy, and (5) several other miscellaneous causes. Results. Over the 3-year time frame of the study, PFO was utilized in 172 of 818 vitrectomy cases (21.0%); 39 of 238 (16.4%) in 1991, 62 of 300 (20.7%) in 1992, and in 71 of 280 (25.4%) in 1993. On a percentage basis, the PFO was utilized most frequently in giant retinal tears (97%), followed by penetrating trauma (40%). proliferative vitreoretinopathy (28%), diabetic vitrectomy (11%), and miscellaneous cases (8%). Individual diagnosis specific success rates will be reviewed, though combining all diagnoses over the 3-year time span, and with follow-up of 6 months, the anatomic success rate was 83.9%. Ambulatory visual acuity (5/200 or better) was achieved in 73.2%. Conclusions. PFO proved to be an extremely useful adjunct in the management of a variety of complex vitreoretinal conditions. While the PFO facilitated intraoperative retinal reattachment, its influence on the overall surgical success rate could not be fully determined due to the non-randomized nature of the study.

UR - http://www.scopus.com/inward/record.url?scp=33750181816&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33750181816&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:33750181816

VL - 37

JO - Investigative Ophthalmology and Visual Science

JF - Investigative Ophthalmology and Visual Science

SN - 0146-0404

IS - 3

ER -